Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Erwinase Market Size Growth Rate by Type
1.3.2 Escherichia coli
1.3.3 Erwinia Chrysanthemi
1.3.4 Pegylated
1.4 Market Segment by Application
1.4.1 Global Erwinase Market Share by Application (2018-2025)
1.4.2 Acute Lymphoblastic Leukemia
1.4.3 Acute Myeloid Leukemia
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Erwinase Market Size
2.1.1 Global Erwinase Revenue 2013-2025
2.1.2 Global Erwinase Sales 2013-2025
2.2 Erwinase Growth Rate by Regions
2.2.1 Global Erwinase Sales by Regions 2013-2018
2.2.2 Global Erwinase Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Erwinase Sales by Manufacturers
3.1.1 Erwinase Sales by Manufacturers 2013-2018
3.1.2 Erwinase Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Erwinase Revenue by Manufacturers (2013-2018)
3.2.2 Erwinase Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Erwinase Market Concentration Ratio (CR5 and HHI)
3.3 Erwinase Price by Manufacturers
3.4 Key Manufacturers Erwinase Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Erwinase Market
3.6 Key Manufacturers Erwinase Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Escherichia coli Sales and Revenue (2013-2018)
4.1.2 Erwinia Chrysanthemi Sales and Revenue (2013-2018)
4.1.3 Pegylated Sales and Revenue (2013-2018)
4.2 Global Erwinase Sales Market Share by Type
4.3 Global Erwinase Revenue Market Share by Type
4.4 Erwinase Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Erwinase Sales by Application
6 North America
6.1 North America Erwinase Breakdown Data by Company
6.2 North America Erwinase Breakdown Data by Type
6.3 North America Erwinase Breakdown Data by Application
6.4 North America Erwinase Breakdown Data by Countries
6.4.1 North America Erwinase Sales by Countries
6.4.2 North America Erwinase Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Erwinase Breakdown Data by Company
7.2 Europe Erwinase Breakdown Data by Type
7.3 Europe Erwinase Breakdown Data by Application
7.4 Europe Erwinase Breakdown Data by Countries
7.4.1 Europe Erwinase Sales by Countries
7.4.2 Europe Erwinase Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Erwinase Breakdown Data by Company
8.2 Asia Pacific Erwinase Breakdown Data by Type
8.3 Asia Pacific Erwinase Breakdown Data by Application
8.4 Asia Pacific Erwinase Breakdown Data by Countries
8.4.1 Asia Pacific Erwinase Sales by Countries
8.4.2 Asia Pacific Erwinase Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Erwinase Breakdown Data by Company
9.2 Central & South America Erwinase Breakdown Data by Type
9.3 Central & South America Erwinase Breakdown Data by Application
9.4 Central & South America Erwinase Breakdown Data by Countries
9.4.1 Central & South America Erwinase Sales by Countries
9.4.2 Central & South America Erwinase Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Erwinase Breakdown Data by Type
10.2 Middle East and Africa Erwinase Breakdown Data by Application
10.3 Middle East and Africa Erwinase Breakdown Data by Countries
10.3.1 Middle East and Africa Erwinase Sales by Countries
10.3.2 Middle East and Africa Erwinase Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa
11 Company Profiles
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Erwinase
11.1.4 Erwinase Product Introduction
11.1.5 Jazz Pharmaceuticals Recent Development
11.2 Shire
11.2.1 Shire Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Erwinase
11.2.4 Erwinase Product Introduction
11.2.5 Shire Recent Development
11.3 Medac GmbH
11.3.1 Medac GmbH Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Erwinase
11.3.4 Erwinase Product Introduction
11.3.5 Medac GmbH Recent Development
11.4 Kyowa Hakko Kirin
11.4.1 Kyowa Hakko Kirin Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Erwinase
11.4.4 Erwinase Product Introduction
11.4.5 Kyowa Hakko Kirin Recent Development
11.5 Qianhong Bio-pharma
11.5.1 Qianhong Bio-pharma Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Erwinase
11.5.4 Erwinase Product Introduction
11.5.5 Qianhong Bio-pharma Recent Development
11.6 Taj Pharmaceuticals
11.6.1 Taj Pharmaceuticals Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Erwinase
11.6.4 Erwinase Product Introduction
11.6.5 Taj Pharmaceuticals Recent Development
11.7 Mingxing Pharma
11.7.1 Mingxing Pharma Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Erwinase
11.7.4 Erwinase Product Introduction
11.7.5 Mingxing Pharma Recent Development
11.8 SL Pharma
11.8.1 SL Pharma Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Erwinase
11.8.4 Erwinase Product Introduction
11.8.5 SL Pharma Recent Development
11.9 United Biotech
11.9.1 United Biotech Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Erwinase
11.9.4 Erwinase Product Introduction
11.9.5 United Biotech Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Erwinase Sales Channels
12.2.2 Erwinase Distributors
12.3 Erwinase Customers
13 Market Forecast
13.1 Global Erwinase Sales and Revenue Forecast 2018-2025
13.2 Global Erwinase Sales Forecast by Type
13.3 Global Erwinase Sales Forecast by Application
13.4 Erwinase Forecast by Regions
13.4.1 Global Erwinase Sales Forecast by Regions 2018-2025
13.4.2 Global Erwinase Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Erwinase Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Erwinase Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Erwinase Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Erwinase Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Erwinase Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Jazz Pharmaceuticals、Shire、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、SL Pharma、United Biotech
【免責事項】
https://www.globalresearch.jp/disclaimer